In vitro activities of a new ketolide, ABT-773, alone and in combination with amoxicillin, metronidazole, or tetracycline against Helicobacter pylori (Q33980565)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	In vitro activities of a new ketolide, ABT-773, alone and in combination with amoxicillin, metronidazole, or tetracycline against Helicobacter pylori	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10952605

retrieved

30 July 2017

title

In vitro activities of a new ketolide, ABT-773, alone and in combination with amoxicillin, metronidazole, or tetracycline against Helicobacter pylori (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10952605

retrieved

30 July 2017

main subject

Helicobacter pylori

1 reference

based on heuristic

inferred from title

tetracycline

1 reference

based on heuristic

inferred from title

amoxicillin

1 reference

based on heuristic

inferred from title

cethromycin

1 reference

based on heuristic

inferred from title

metronidazole

1 reference

based on heuristic

inferred from title

author name string

Pendland SL

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10952605

retrieved

30 July 2017

Prause JL

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10952605

retrieved

30 July 2017

Neuhauser MM

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10952605

retrieved

30 July 2017

Boyea N

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10952605

retrieved

30 July 2017

Hackleman JM

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10952605

retrieved

30 July 2017

Danziger LH

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10952605

retrieved

30 July 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10952605

retrieved

30 July 2017

published in

Antimicrobial Agents and Chemotherapy

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10952605

retrieved

30 July 2017

volume

44

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10952605

retrieved

30 July 2017

issue

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10952605

retrieved

30 July 2017

page(s)

2518-2520

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10952605

retrieved

30 July 2017

cites work

Antimicrobial susceptibility testing of 230 Helicobacter pylori strains: importance of medium, inoculum, and incubation time

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90095

retrieved

5 July 2018

In vitro synergy testing of clarithromycin and 14-hydroxyclarithromycin with amoxicillin or bismuth subsalicylate against Helicobacter pylori

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90095

retrieved

5 July 2018

Metronidazole susceptibility testing for Helicobacter pylori: comparison of disk, broth, and agar dilution methods and their clinical relevance

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90095

retrieved

5 July 2018

In-vitro synergy of paromomycin with metronidazole alone or metronidazole plus hydroxymetronidazole against Helicobacter pylori

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90095

retrieved

29 October 2018

Additive effect of clarithromycin combined with 14-hydroxy clarithromycin, erythromycin, amoxycillin, metronidazole or omeprazole against Helicobacter pylori

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/10952605

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/10952605

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1128/AAC.44.9.2518-2520.2000

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10952605

retrieved

30 July 2017

PMC publication ID

90095

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10952605

retrieved

30 July 2017

PubMed publication ID

10952605

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10952605

retrieved

30 July 2017

ResearchGate publication ID

12367586

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33980565&oldid=1582823889"